Please login to the form below

Not currently logged in
Email:
Password:

Hive Health appoints Mike Walker as brand development director

He joins the London-based healthcare comms agency from BBH

Mike WalkerLondon-based healthcare communications agency Hive Health has appointed Mike Walker as brand development director.

He brings over 25 years of global and local brand development expertise, most recently from BBH London, where he served as a creative director working on global healthcare business.

While there his role saw him act as global creative director for the world's biggest-selling drug, Humira, leading the strategic direction for the brand’s portfolio of indications.

Prior to his time at BBH Walker served at the likes of Saatchi & Saatchi Healthcare, Grey Healthcare and McCann Erickson Healthcare.

Hive Health director Jas Hummel said: “Mike’s experience in global brand strategy combined with his creative pedigree means he brings a unique perspective to brand development. He’s a perfect match for our proposition and culture”

Walker added: "Hive’s proposition has always intrigued me. Many people assume that this agency’s core offering is patient insight generation and patient communication. Far from it.

"What excites me is what happens when you put the patient experience at the heart of brand strategy; it opens up completely new ways to see opportunities and find innovative solutions."

27th September 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics